 | Heron Therapeutics Inc (NASDAQ:HRTX) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - July 8 at 12:10 PM |
| FY2020 EPS Estimates for Heron Therapeutics Inc Increased by Cantor Fitzgerald (NASDAQ:HRTX)
www.americanbankingnews.com - July 3 at 7:05 AM |
| Jefferies Financial Group Comments on Heron Therapeutics Inc's FY2020 Earnings (NASDAQ:HRTX)
www.americanbankingnews.com - July 2 at 9:18 AM |
| Q3 2020 EPS Estimates for Heron Therapeutics Inc (NASDAQ:HRTX) Decreased by SVB Leerink
www.americanbankingnews.com - July 2 at 8:33 AM |
| Zacks: Analysts Expect Heron Therapeutics Inc (NASDAQ:HRTX) Will Announce Quarterly Sales of $15.45 Million
www.americanbankingnews.com - July 2 at 2:28 AM |
 | U.S. FDA again declines to approve Heron Therapeutics' non-opioid painkiller
www.nasdaq.com - July 1 at 6:39 PM |
| -$0.61 Earnings Per Share Expected for Heron Therapeutics Inc (NASDAQ:HRTX) This Quarter
www.americanbankingnews.com - June 30 at 5:50 PM |
| Heron's Pain Management Drug Gets Complete Response Letter
www.nasdaq.com - June 30 at 2:06 PM |
 | Heron Therapeutics: The Play Now
seekingalpha.com - June 30 at 2:06 PM |
 | Heron's Pain Management Drug Gets Complete Response Letter
finance.yahoo.com - June 30 at 2:06 PM |
|
 | Heron Therapeutics (NASDAQ:HRTX) Shares Gap Down Following Analyst Downgrade
www.marketbeat.com - June 30 at 1:26 PM |
| Heron Therapeutics (NASDAQ:HRTX) Given New $19.00 Price Target at SVB Leerink
www.marketbeat.com - June 30 at 11:28 AM |
| Heron Therapeutics Sees Unusually Large Options Volume (NASDAQ:HRTX)
www.americanbankingnews.com - June 30 at 8:04 AM |
| Stifel Nicolaus Begins Coverage on Heron Therapeutics (NASDAQ:HRTX)
www.americanbankingnews.com - June 30 at 6:33 AM |
 | Mid-Day Market Update: Crude Oil Up 1.5%; Heron Therapeutics Shares Plummet
www.benzinga.com - June 29 at 1:43 PM |
| Stock Alert: Heron Therapeutics Slips 30% Following FDA Letter
www.nasdaq.com - June 29 at 1:43 PM |
| FDA rejects Heron Therapeutics' NDA for HTX-011 for postoperative pain
seekingalpha.com - June 29 at 1:43 PM |
| Heron Gets CRL For HTX-011 For Management Of Postoperative Pain; Stock Down
www.nasdaq.com - June 29 at 1:42 PM |
 | Why Heron Therapeutics Stock Is Tanking Today
www.fool.com - June 29 at 1:42 PM |
| Implied Volatility Surging for Heron Therapeutics (HRTX) Stock Options
finance.yahoo.com - June 29 at 1:42 PM |
| Heron Therapeutics Target of Unusually Large Options Trading (NASDAQ:HRTX)
www.americanbankingnews.com - June 29 at 11:10 AM |
| Heron Therapeutics (NASDAQ:HRTX) Now Covered by Northland Securities
www.americanbankingnews.com - June 23 at 1:40 PM |
| 2 Top Healthcare Stocks to Watch in June
finance.yahoo.com - June 16 at 10:20 AM |
 | Postoperative Pain Therapeutics Market 2020-2025 | Industry Trends, Size, Share, Growth, Demand, COVID-19 Impact Analysis, And Future Scope
www.marketwatch.com - June 15 at 8:01 AM |
| Heron's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - June 8 at 12:47 PM |
| Heron's HTX-011 shows benefit in mid-stage knee replacement study
seekingalpha.com - June 4 at 12:30 PM |
| Heron Therapeutics Announces Publication of Results from Study 209, a Phase 2b Study of HTX-011 in Patients Undergoing Total Knee Arthroplasty
finance.yahoo.com - June 4 at 12:30 PM |
| Why Heron Therapeutics's Stock Is Trading Higher Today
www.benzinga.com - May 27 at 2:39 PM |
| Billionaire Jim Simons Pulls the Trigger on These 3 Healthcare Stocks
finance.yahoo.com - May 20 at 10:49 AM |
| Heron launches study of HTX-034 for postop pain
seekingalpha.com - May 18 at 2:46 PM |
|
| Heron Therapeutics Announces Initiation of Phase 1b/2 Clinical Study of HTX-034 for the Treatment of Postoperative Pain
finance.yahoo.com - May 18 at 9:46 AM |
| 3 Best Healthcare Stocks to Buy in May
finance.yahoo.com - May 9 at 8:12 AM |
| Earnings Update: Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Reported And Analysts Are Trimming Their Forecasts
finance.yahoo.com - May 8 at 5:07 PM |
| Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Industry – Growth, Trends, and Forecast (2020 – 2025)
www.marketwatch.com - May 7 at 2:29 PM |
| Heron Therapeutics EPS beats by $0.08, beats on revenue
seekingalpha.com - May 6 at 12:21 PM |
| Does Heron Therapeutics, Inc. (NASDAQ:HRTX) Have A Particularly Volatile Share Price?
finance.yahoo.com - May 5 at 9:35 AM |
 | 2 Dirt-Cheap Growth Stocks to Buy Now
www.msn.com - April 9 at 10:04 PM |
| Do Hedge Funds Love Heron Therapeutics Inc (HRTX)?
finance.yahoo.com - April 7 at 4:00 PM |
| Despite Lacking Profits Heron Therapeutics (NASDAQ:HRTX) Seems To Be On Top Of Its Debt
finance.yahoo.com - April 5 at 3:35 PM |
 | Final Deadline: (HRTX) Heron Therapeutics, Inc. - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action and Lead
www.bloomberg.com - March 30 at 8:04 PM |
| Heron Therapeutics, Inc. Common Stock (HRTX) Option Chain
www.nasdaq.com - March 21 at 1:59 PM |
| Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market 2020 Demand, Supply, Growth and Forecast to 2025
www.marketwatch.com - March 18 at 8:06 AM |
| Heron Therapeutics Becomes Oversold (HRTX)
www.nasdaq.com - March 6 at 12:25 PM |
| Heron Therapeutics (HRTX) Presents At SVB Leerink Global Healthcare Conference - Slideshow
seekingalpha.com - March 5 at 4:24 PM |
| Heron Therapeutics EPS misses by $0.09, beats on revenue
seekingalpha.com - March 2 at 7:55 AM |
| Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2019 and Highlights Recent Corporate Updates
finance.yahoo.com - March 2 at 7:55 AM |
| Analysts: 3 Beaten-Down Stocks to Buy on Weakness
finance.yahoo.com - February 27 at 2:03 PM |
| Heron Therapeutics: Generic Competition And HTX-011 Approval May Put Pressure On Share Price
seekingalpha.com - February 25 at 2:00 PM |
| Heron Therapeutics: Looking For Entry Following HTX-011 PDUFA Extension
seekingalpha.com - February 21 at 6:42 PM |
| Heron Therapeutics (HRTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
finance.yahoo.com - February 21 at 1:40 PM |
